These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16081964)

  • 1. Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus.
    Lu JJ; Lee SY; Hwa SY; Yang AH
    J Clin Microbiol; 2005 Aug; 43(8):4156-8. PubMed ID: 16081964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.
    Fridkin SK; Hageman J; McDougal LK; Mohammed J; Jarvis WR; Perl TM; Tenover FC;
    Clin Infect Dis; 2003 Feb; 36(4):429-39. PubMed ID: 12567300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of the MRSA clone with reduced susceptibility to vancomycin].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 2000; 52(3):223-8. PubMed ID: 11147263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada.
    Webster D; Rennie RP; Brosnikoff CL; Chui L; Brown C
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):177-81. PubMed ID: 16938420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains.
    Drummelsmith J; Winstall E; Bergeron MG; Poirier GG; Ouellette M
    J Proteome Res; 2007 Dec; 6(12):4690-702. PubMed ID: 17997515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia.
    Naimi TS; Anderson D; O'Boyle C; Boxrud DJ; Johnson SK; Tenover FC; Lynfield R
    Clin Infect Dis; 2003 Jun; 36(12):1609-12. PubMed ID: 12802763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
    Bhateja P; Purnapatre K; Dube S; Fatma T; Rattan A
    Int J Antimicrob Agents; 2006 Mar; 27(3):201-11. PubMed ID: 16417988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection methods for drug-resistant bacteria in routine examination--VISA].
    Kinoshita S; Nakamachi Y
    Rinsho Byori; 2000 Jan; Suppl 111():69-74. PubMed ID: 10804795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
    Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
    Lin YT; Tsai JC; Yamamoto T; Chen HJ; Hung WC; Hsueh PR; Teng LJ
    J Antimicrob Chemother; 2016 Jul; 71(7):1807-14. PubMed ID: 26968883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea.
    Kim HB; Lee YS; Kim BS; Cha JO; Kwon SU; Lee HJ; Suh JT; Rheem I; Kim JM; Shin BM; Kim MN; Lee K; Lee CS; Kim EC; Oh MD; Choe KW
    Microb Drug Resist; 2006; 12(1):33-8. PubMed ID: 16584306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F
    J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
    Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.